LabCorp and Netflix
Back in November 2008, 84 percent of respondents to an ADVANCE Opinion Poll question said they were feeling the pinch of the economy at their workplaces. As the country's financial situation continues to worsen, how is it impacting you professionally? Are you seeing educational budgets slashed, meaning less conferences and seminars? Are you or your supervisors going over supply requisitions with a fine-toothed comb?
What about the work itself? How is the current economic climate impacting your testing volumes?
In a report published yesterday in MarketWatch, a Wall Street Journal Digital Network affiliate, Steven Barry and colleagues from the Goldman Sachs growth-stock team identified companies that could thrive in these tough times; including LabCorp.
While Barry acknowledged fears that belt-tightening for some families could include deferring medical care, he says it's unlikely. Instead, he predicts LabCorp "stands to benefit from strong pricing power and generates ‘prodigious cash flow' he expects will go toward share buybacks."
If volumes are dropping, is your facility reacting by doing more tests in-house to capitalize on revenues? Or are you outsourcing more rare tests as volumes sink even lower?